Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Seaman

Showing results (191-200 of 415) with videos related to

Pageof 42
Sort By:
The Journal of Clinical Investigation|November 3, 2004
Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccinesShawn M Sumida, Paul F McKay, Diana M Truitt, et al.
The Journal of Infectious Diseases|March 31, 2010
Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with DryvaxMichael S Seaman, Marissa B Wilck, Lindsey R Baden, et al.
The Journal of Infectious Diseases|March 31, 2010
Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administrationMarissa B Wilck, Michael S Seaman, Lindsey R Baden, et al.
Cell Reports|April 29, 2014
Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spikeLouise Scharf, Johannes F Scheid, Jeong Hyun Lee, et al.
The Journal of Experimental Medicine|May 30, 2012
Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunizationLaura E McCoy, Anna Forsman Quigley, Nika M Strokappe, et al.
Journal of Virology|February 27, 2024
A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelopeVinita R Joshi, Daniel T Claiborne, Melissa L Pack, et al.
JCI Insight|September 6, 2019
Predicting the broadly neutralizing antibody susceptibility of the HIV reservoirWen-Han Yu, David Su, Julia Torabi, et al.
Journal of Virology|July 5, 2005
Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responsesKeith A Reimann, Robert A Parker, Michael S Seaman, et al.
Journal of Immunological Methods|December 3, 2013
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1Marcella Sarzotti-Kelsoe, Robert T Bailer, Ellen Turk, et al.
The Journal of Experimental Medicine|May 29, 2013
Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodiesRon Diskin, Florian Klein, Joshua A Horwitz, et al.
Pageof 42

Showing results (191-200 of 415) with videos related to

Sort By:
Pageof 42
The Journal of Clinical Investigation|November 3, 2004
Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccinesShawn M Sumida, Paul F McKay, Diana M Truitt, et al.
The Journal of Infectious Diseases|March 31, 2010
Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with DryvaxMichael S Seaman, Marissa B Wilck, Lindsey R Baden, et al.
The Journal of Infectious Diseases|March 31, 2010
Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administrationMarissa B Wilck, Michael S Seaman, Lindsey R Baden, et al.
Cell Reports|April 29, 2014
Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spikeLouise Scharf, Johannes F Scheid, Jeong Hyun Lee, et al.
The Journal of Experimental Medicine|May 30, 2012
Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunizationLaura E McCoy, Anna Forsman Quigley, Nika M Strokappe, et al.
Journal of Virology|February 27, 2024
A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelopeVinita R Joshi, Daniel T Claiborne, Melissa L Pack, et al.
JCI Insight|September 6, 2019
Predicting the broadly neutralizing antibody susceptibility of the HIV reservoirWen-Han Yu, David Su, Julia Torabi, et al.
Journal of Virology|July 5, 2005
Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responsesKeith A Reimann, Robert A Parker, Michael S Seaman, et al.
Journal of Immunological Methods|December 3, 2013
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1Marcella Sarzotti-Kelsoe, Robert T Bailer, Ellen Turk, et al.
The Journal of Experimental Medicine|May 29, 2013
Restricting HIV-1 pathways for escape using rationally designed anti-HIV-1 antibodiesRon Diskin, Florian Klein, Joshua A Horwitz, et al.
Pageof 42